Potential Therapeutic Use of Stem Cells for Prion Diseases
暂无分享,去创建一个
[1] M. Zabel,et al. Intranasally delivered mesenchymal stromal cells decrease glial inflammation early in prion disease , 2023, Frontiers in Neuroscience.
[2] R. Bolea,et al. Susceptibility of Ovine Bone Marrow-Derived Mesenchymal Stem Cell Spheroids to Scrapie Prion Infection , 2023, Animals : an open access journal from MDPI.
[3] S. Kook,et al. Prion infection modulates hematopoietic stem/progenitor cell fate through cell-autonomous and non-autonomous mechanisms , 2023, Leukemia.
[4] Cheng-I Lee,et al. Combination of structure-based virtual screening, molecular docking and molecular dynamics approaches for the discovery of anti-prion fibril flavonoids , 2023, Frontiers in Molecular Biosciences.
[5] M. Zabel,et al. Adipose-derived mesenchymal stromal cells decrease prion-induced glial inflammation in vitro , 2022, Scientific Reports.
[6] K. Shim,et al. Prion therapeutics: Lessons from the past , 2022, Prion.
[7] R. Nonno,et al. An optimized Western blot assay provides a comprehensive assessment of the physiological endoproteolytic processing of the prion protein , 2022, The Journal of biological chemistry.
[8] M. Bolognesi,et al. Bifunctional carbazole derivatives for simultaneous therapy and fluorescence imaging in prion disease murine cell models. , 2022, European journal of medicinal chemistry.
[9] Zhizhong Shang,et al. Clinical translation of stem cell therapy for spinal cord injury still premature: results from a single-arm meta-analysis based on 62 clinical trials , 2022, BMC Medicine.
[10] B. Jeong,et al. Creutzfeldt-Jakob Disease Incidence, South Korea, 2001–2019 , 2022, Emerging infectious diseases.
[11] M. Heke,et al. Stem cell-based therapy for human diseases , 2022, Signal Transduction and Targeted Therapy.
[12] Milad Shirvaliloo,et al. The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment , 2022, Stem cell research & therapy.
[13] Mengqin Yuan,et al. Mesenchymal stromal cells: promising treatment for liver cirrhosis , 2022, Stem Cell Research & Therapy.
[14] Jinqiu Zhang,et al. Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? , 2022, Cell Death & Disease.
[15] D. Dafou,et al. Carnosic Acid and Carnosol Display Antioxidant and Anti-Prion Properties in In Vitro and Cell-Free Models of Prion Diseases , 2022, Antioxidants.
[16] B. Caughey,et al. Real-Time Quaking- Induced Conversion Assays for Prion Diseases, Synucleinopathies, and Tauopathies , 2022, Frontiers in Aging Neuroscience.
[17] M. Bolognesi,et al. Therapeutic strategies for identifying small molecules against prion diseases , 2022, Cell and Tissue Research.
[18] B. Jeong,et al. In-depth examination of PrPSc in Holstein cattle carrying the E211K somatic mutation of the bovine prion protein gene (PRNP). , 2021, Transboundary and emerging diseases.
[19] Yong-Chan Kim,et al. Altered expression of glymphatic system-related proteins in prion diseases: Implications for the role of the glymphatic system in prion diseases , 2021, Cellular & Molecular Immunology.
[20] S. Méndez-Ferrer,et al. Cellular Heterogeneity of Mesenchymal Stem/Stromal Cells in the Bone Marrow , 2021, Frontiers in Cell and Developmental Biology.
[21] M. Nakashima,et al. Characterization of stable hypoxia-preconditioned dental pulp stem cells compared with mobilized dental pulp stem cells for application for pulp regenerative therapy , 2021, Stem Cell Research & Therapy.
[22] R. Bolea,et al. Effect of Scrapie Prion Infection in Ovine Bone Marrow-Derived Mesenchymal Stem Cells and Ovine Mesenchymal Stem Cell-Derived Neurons , 2021, Animals : an open access journal from MDPI.
[23] Caihong Zhu,et al. Neuroinflammation in Prion Disease , 2021, International journal of molecular sciences.
[24] M. Nakashima,et al. Characterization of stable hypoxia-preconditioned dental pulp stem cells compared with mobilized dental pulp stem cells for application for pulp regenerative therapy , 2021, Stem cell research & therapy.
[25] M. Krampera,et al. Extracellular Vesicle-Dependent Communication Between Mesenchymal Stromal Cells and Immune Effector Cells , 2020, Frontiers in Cell and Developmental Biology.
[26] A. A. Galiakberova,et al. Neural Stem Cells and Methods for Their Generation From Induced Pluripotent Stem Cells in vitro , 2020, Frontiers in Cell and Developmental Biology.
[27] V. Tkachuk,et al. Mesenchymal Stromal Cells as Critical Contributors to Tissue Regeneration , 2020, Frontiers in Cell and Developmental Biology.
[28] Lei Lei,et al. Tumorigenic and Immunogenic Properties of Induced Pluripotent Stem Cells: a Promising Cancer Vaccine , 2020, Stem Cell Reviews and Reports.
[29] Lin-Po Yang,et al. Stem cell therapy for Alzheimer's disease , 2020, World journal of stem cells.
[30] K. Iohara,et al. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019 , 2020, Cell transplantation.
[31] Zunjin Liu,et al. Stem cell-based therapies for ischemic stroke: a systematic review and meta-analysis of clinical trials , 2020, Stem Cell Research & Therapy.
[32] F. Santilli,et al. Prion Protein in Stem Cells: A Lipid Raft Component Involved in the Cellular Differentiation Process , 2020, International journal of molecular sciences.
[33] Suleiman Yusuf Alhaji,et al. Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy , 2020, BioResearch open access.
[34] F. Rizzo,et al. Neural Stem Cell Transplantation for Neurodegenerative Diseases , 2020, International journal of molecular sciences.
[35] M. Bolognesi,et al. In silico/in vitro screening and hit evaluation identified new phenothiazine anti-prion derivatives. , 2020, European journal of medicinal chemistry.
[36] Baoan Chen,et al. Mesenchymal stem cells: a promising way in therapies of graft-versus-host disease , 2020, Cancer Cell International.
[37] S. Chand,et al. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Challenges in Clinical Applications , 2020, Frontiers in Cell and Developmental Biology.
[38] Maximilian T. Strauss,et al. Cellular models for discovering prion disease therapeutics: Progress and challenges , 2020, Journal of neurochemistry.
[39] I. Zerr,et al. Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency , 2019, Molecular Neurobiology.
[40] S. Schreiber,et al. Antisense oligonucleotides extend survival of prion-infected mice , 2019, JCI insight.
[41] Hyung-Sik Kim,et al. Current Strategies to Enhance Adipose Stem Cell Function: An Update , 2019, International journal of molecular sciences.
[42] Yanbo Zhang,et al. Mesenchymal Stem Cells for Regenerative Medicine , 2019, Cells.
[43] P. Peláez,et al. Adipose-Derived Mesenchymal Stem Cells: A Promising Tool in the Treatment of Musculoskeletal Diseases , 2019, International journal of molecular sciences.
[44] D. Harris,et al. Prion neurotoxicity , 2019, Brain pathology.
[45] M. D. Di Bari,et al. Full restoration of specific infectivity and strain properties from pure mammalian prion protein , 2019, PLoS pathogens.
[46] Wojciech Zakrzewski,et al. Stem cells: past, present, and future , 2019, Stem cell research & therapy.
[47] R. Chiesa,et al. Experimental models to study prion disease pathogenesis and identify potential therapeutic compounds. , 2019, Current opinion in pharmacology (Print).
[48] Taeyoung Kang,et al. Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles , 2018, Nucleic Acids Res..
[49] A. Aguzzi,et al. Prions, prionoids and protein misfolding disorders , 2018, Nature Reviews Genetics.
[50] V. Cavalli,et al. Intrinsic mechanisms of neuronal axon regeneration , 2018, Nature Reviews Neuroscience.
[51] M. Ghahremani,et al. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine , 2018, Stem Cell Research & Therapy.
[52] F. Santilli,et al. Role of Prion protein-EGFR multimolecular complex during neuronal differentiation of human dental pulp-derived stem cells , 2018, Prion.
[53] V. Cecchetti,et al. Pharmacological Agents Targeting the Cellular Prion Protein , 2018, Pathogens.
[54] S. Chandran,et al. Human stem cell–derived astrocytes replicate human prions in a PRNP genotype–dependent manner , 2017, The Journal of experimental medicine.
[55] M. Horiuchi,et al. Therapeutic effect of autologous compact bone-derived mesenchymal stem cell transplantation on prion disease. , 2017, The Journal of general virology.
[56] D. Dufrane. Impact of Age on Human Adipose Stem Cells for Bone Tissue Engineering , 2017, Cell transplantation.
[57] A. Castle,et al. Physiological Functions of the Cellular Prion Protein , 2017, Front. Mol. Biosci..
[58] J. Frydman,et al. Protein misfolding in neurodegenerative diseases: implications and strategies , 2017, Translational Neurodegeneration.
[59] M. Dhar,et al. Donor-Matched Comparison of Chondrogenic Potential of Equine Bone Marrow- and Synovial Fluid-Derived Mesenchymal Stem Cells: Implications for Cartilage Tissue Regeneration , 2017, Front. Vet. Sci..
[60] S. Y. Kim,et al. Anti-Prion Screening for Acridine, Dextran, and Tannic Acid using Real Time–Quaking Induced Conversion: A Comparison with PrPSc-Infected Cell Screening , 2017, PloS one.
[61] S. Brandner,et al. Prion disease: experimental models and reality , 2017, Acta Neuropathologica.
[62] B. Caughey,et al. Diagnostic and prognostic value of human prion detection in cerebrospinal fluid , 2017, Annals of neurology.
[63] S. Pluchino,et al. Modulation of host immune responses following non-hematopoietic stem cell transplantation: Translational implications in progressive multiple sclerosis , 2016, Journal of Neuroimmunology.
[64] G. Baron,et al. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection , 2016, Journal of Virology.
[65] M. Dhar,et al. Effects of pro-inflammatory cytokines on chondrogenesis of equine mesenchymal stromal cells derived from bone marrow or synovial fluid. , 2016, Veterinary journal.
[66] S. Guan,et al. Optimization of Aryl Amides that Extend Survival in Prion-Infected Mice , 2016, The Journal of Pharmacology and Experimental Therapeutics.
[67] Ankur A Patel,et al. Stem Cell Therapy for Alzheimer's Disease , 2016, 1608.07499.
[68] D. Varges,et al. Application of an in vitro-amplification assay as a novel pre-screening test for compounds inhibiting the aggregation of prion protein scrapie , 2016, Scientific Reports.
[69] H. Tse,et al. Mesenchymal stem cells and immunomodulation: current status and future prospects , 2016, Cell Death and Disease.
[70] S. Guan,et al. Different 2-Aminothiazole Therapeutics Produce Distinct Patterns of Scrapie Prion Neuropathology in Mouse Brains , 2015, The Journal of Pharmacology and Experimental Therapeutics.
[71] Mingfen Li,et al. Mesenchymal stem cells suppress CD8+ T cell‐mediated activation by suppressing natural killer group 2, member D protein receptor expression and secretion of prostaglandin E2, indoleamine 2, 3‐dioxygenase and transforming growth factor‐β , 2014, Clinical and experimental immunology.
[72] Derek H. Oakley,et al. Stem cells in the nervous system. , 2014, American journal of physical medicine & rehabilitation.
[73] H. Tse,et al. Paracrine Mechanisms of Mesenchymal Stem Cell-Based Therapy: Current Status and Perspectives , 2014, Cell transplantation.
[74] S. Prusiner,et al. Mouse Models for Studying the Formation and Propagation of Prions* , 2014, The Journal of Biological Chemistry.
[75] Yong-Sun Kim,et al. Genetic Studies in Human Prion Diseases , 2014, Journal of Korean medical science.
[76] P. Pascutti,et al. Anti-Prion Activity of a Panel of Aromatic Chemical Compounds: In Vitro and In Silico Approaches , 2014, PloS one.
[77] Camilo Duque Velásquez,et al. Infectious Prions Accumulate to High Levels in Non Proliferative C2C12 Myotubes , 2013, PLoS pathogens.
[78] Zhe Li,et al. Biaryl Amides and Hydrazones as Therapeutics for Prion Disease in Transgenic Mice , 2013, The Journal of Pharmacology and Experimental Therapeutics.
[79] S. Prusiner,et al. Drug resistance confounding prion therapeutics , 2013, Proceedings of the National Academy of Sciences.
[80] P. Fischer,et al. Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice , 2013, Science Translational Medicine.
[81] A. Gabelle,et al. Prion Replication Occurs in Endogenous Adult Neural Stem Cells and Alters Their Neuronal Fate: Involvement of Endogenous Neural Stem Cells in Prion Diseases , 2013, PLoS pathogens.
[82] C. Simmons,et al. Mesenchymal stem cell mechanobiology and emerging experimental platforms , 2013, Journal of The Royal Society Interface.
[83] M. Hoogduijn,et al. Mesenchymal Stem Cells: Are We Ready for Clinical Application in Transplantation and Tissue Regeneration? , 2013, Front. Immunol..
[84] F. Djouad,et al. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells , 2013, Stem Cell Research & Therapy.
[85] R. Bolea,et al. Isolation and characterization of ovine mesenchymal stem cells derived from peripheral blood , 2012, BMC Veterinary Research.
[86] W. Keith,et al. A Small Molecule Modulator of Prion Protein Increases Human Mesenchymal Stem Cell Lifespan, Ex Vivo Expansion, and Engraftment to Bone Marrow in NOD/SCID Mice , 2012, Stem cells.
[87] R. Xu,et al. Concise Review: Genomic Stability of Human Induced Pluripotent Stem Cells , 2012, Stem cells.
[88] J. Torres,et al. Stem cell therapy extends incubation and survival time in prion-infected mice in a time window-dependant manner. , 2011, The Journal of infectious diseases.
[89] H. Furuoka,et al. Identification of Chemoattractive Factors Involved in the Migration of Bone Marrow-Derived Mesenchymal Stem Cells to Brain Lesions Caused by Prions , 2011, Journal of Virology.
[90] S. Böhm,et al. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC , 2011, Cell Communication and Signaling.
[91] J. Choi,et al. Reduction of Prion Infectivity and Levels of Scrapie Prion Protein By Lithium Aluminum Hydride: Implications for RNA in Prion Diseases , 2009, Journal of neuropathology and experimental neurology.
[92] J. Castilla,et al. In Vivo Generation of Neurotoxic Prion Protein: Role for Hsp70 in Accumulation of Misfolded Isoforms , 2009, PLoS genetics.
[93] B. Lo,et al. Ethical issues in stem cell research. , 2009, Endocrine reviews.
[94] H. Furuoka,et al. Effect of Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells on Mice Infected with Prions , 2009, Journal of Virology.
[95] J. Kira,et al. Bone marrow stroma cells are susceptible to prion infection. , 2008, Biochemical and biophysical research communications.
[96] M. Gnecchi,et al. Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.
[97] A. Aguzzi,et al. The prion's elusive reason for being. , 2008, Annual review of neuroscience.
[98] Joel S Greenberger,et al. Age‐related intrinsic changes in human bone‐marrow‐derived mesenchymal stem cells and their differentiation to osteoblasts , 2008, Aging cell.
[99] I. Izquierdo,et al. Physiology of the prion protein. , 2008, Physiological reviews.
[100] C. Julius,et al. Prion strain discrimination in cell culture: The cell panel assay , 2007, Proceedings of the National Academy of Sciences.
[101] F. Cohen,et al. Cell division modulates prion accumulation in cultured cells , 2007, Proceedings of the National Academy of Sciences.
[102] K. Doh-ura,et al. Orally Administered Amyloidophilic Compound Is Effective in Prolonging the Incubation Periods of Animals Cerebrally Infected with Prion Diseases in a Prion Strain-Dependent Manner , 2007, Journal of Virology.
[103] M. Horiuchi,et al. Characterization of Prion Susceptibility in Neuro2a Mouse Neuroblastoma Cell Subclones , 2007, Microbiology and immunology.
[104] S. Jacchieri,et al. Cellular prion protein interaction with vitronectin supports axonal growth and is compensated by integrins , 2007, Journal of Cell Science.
[105] D. Harris,et al. The cellular prion protein (PrP(C)): its physiological function and role in disease. , 2007, Biochimica et biophysica acta.
[106] H. Schätzl,et al. Antibodies to a Nonconjugated Prion Protein Peptide 95-123 Interfere with PrPSc Propagation in Prion-Infected Cells , 2007, Cellular and Molecular Neurobiology.
[107] M. Shinagawa,et al. Microglial Cell Line Established from Prion Protein-Overexpressing Mice Is Susceptible to Various Murine Prion Strains , 2006, Journal of Virology.
[108] R. McKay,et al. Neural Stem Cell Model for Prion Propagation , 2006, Stem cells.
[109] Anoop P. Patel,et al. Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. , 2006, Blood.
[110] D. Westaway,et al. The Expanding Universe of Prion Diseases , 2006, PLoS pathogens.
[111] Andrew D. Steele,et al. Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[112] Andrew D. Steele,et al. Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[113] R. Linden,et al. Interaction of Cellular Prion and Stress-Inducible Protein 1 Promotes Neuritogenesis and Neuroprotection by Distinct Signaling Pathways , 2005, The Journal of Neuroscience.
[114] Neil R. Cashman,et al. Prion diseases — close to effective therapy? , 2004, Nature Reviews Drug Discovery.
[115] A. Aguzzi,et al. Mammalian Prion Biology One Century of Evolving Concepts , 2004, Cell.
[116] Sebastian Brandner,et al. Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis , 2003, Science.
[117] J. Cesbron,et al. PrP Expression and Replication by Schwann Cells: Implications in Prion Spreading , 2002, Journal of Virology.
[118] J. Fraser,et al. Fetal cell grafts provide long-term protection against scrapie induced neuronal loss , 2001, Neuroreport.
[119] A. Favier,et al. Prion infection impairs the cellular response to oxidative stress. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[120] K Wüthrich,et al. NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[121] D. Harris,et al. Successful Transmission of Three Mouse-Adapted Scrapie Strains to Murine Neuroblastoma Cell Lines Overexpressing Wild-Type Mouse Prion Protein , 2000, Journal of Virology.
[122] Y. Kim,et al. Molecular analysis of prion protein gene (PRNP) in Korean patients with Creutzfeldt-Jakob disease. , 1998, Journal of Korean medical science.
[123] A. Hofman,et al. A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.
[124] A. Aguzzi,et al. Normal host prion protein necessary for scrapie-induced neurotoxicity , 1996, Nature.
[125] R. Colello,et al. Developmental expression of the prion protein gene in glial cells , 1995, Neuron.
[126] A. Aguzzi,et al. Mice devoid of PrP are resistant to scrapie , 1993, Cell.
[127] N. Cashman,et al. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein , 1992, Neurology.
[128] S. Prusiner,et al. Molecular biology of prion diseases , 1991, Science.
[129] A. Friedenstein,et al. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers , 1987, Cell and tissue kinetics.
[130] Ludmila Buravkova. Mesenchymal stromal cells (MSCs) , 2020 .
[131] I. Zerr,et al. Amplification and Detection of Minuscule Amounts of Misfolded Prion Protein by Using the Real-Time Quaking-Induced Conversion. , 2018, Methods in molecular biology.
[132] M. Ciuffreda,et al. Paracrine Mechanisms of Mesenchymal Stem Cells in Tissue Repair. , 2016, Methods in molecular biology.
[133] Claudio Soto,et al. The intricate mechanisms of neurodegeneration in prion diseases. , 2011, Trends in molecular medicine.
[134] C. Masters,et al. Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture. , 2008, The international journal of biochemistry & cell biology.
[135] C. Zurzolo,et al. Prions , 2007, Journal of Molecular Neuroscience.
[136] D. Prockop,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.
[137] S. Prusiner,et al. Scrapie prion proteins are synthesized in neurons. , 1986, The American journal of pathology.